Ispecimen inc. announces closing of $5 million public offering of common stock and pre-funded warrants

Woburn, mass., oct. 31, 2024 (globe newswire) -- ispecimen inc. (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced public offering of approximately $5 million of the company's common stock and pre-funded warrants to purchase shares of common stock at a public offering price of $3.00 per share (minus $0.0001 per pre-funded warrant). the company intends to use the proceeds of the offering for repayment of outstanding debt, potential acquisitions of assets or investments in businesses, products and technologies and for marketing and advertising services. the remainder of the proceeds will be used for working capital purposes.
ISPC Ratings Summary
ISPC Quant Ranking